These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

627 related items for PubMed ID: 33054750

  • 1. Higher levels of the soluble receptor for advanced glycation end products and lower levels of the extracellular newly identified receptor for advanced glycation end products were associated with lipid-lowering drugs in patients with type 1 diabetes: a comparative cross-sectional study.
    Melin EO, Dereke J, Hillman M.
    Lipids Health Dis; 2020 Oct 14; 19(1):223. PubMed ID: 33054750
    [Abstract] [Full Text] [Related]

  • 2. Plasma levels of soluble receptor for advanced glycation end products (sRAGE) and proinflammatory ligand for RAGE (EN-RAGE) are associated with carotid atherosclerosis in patients with peritoneal dialysis.
    Kim JK, Park S, Lee MJ, Song YR, Han SH, Kim SG, Kang SW, Choi KH, Kim HJ, Yoo TH.
    Atherosclerosis; 2012 Jan 14; 220(1):208-14. PubMed ID: 21906738
    [Abstract] [Full Text] [Related]

  • 3. Circulating levels of soluble receptor for advanced glycation end products and ligands of the receptor for advanced glycation end products in patients with acute liver failure.
    Basta G, Del Turco S, Navarra T, Lee WM, Acute Liver Failure Study Group.
    Liver Transpl; 2015 Jun 14; 21(6):847-54. PubMed ID: 25825217
    [Abstract] [Full Text] [Related]

  • 4. Elevated Circulating S100A12 Associates with Vascular Disease and Worse Clinical Outcome in Peritoneal Dialysis Patients.
    Isoyama N, Machowska A, Qureshi AR, Yamamoto T, Anderstam B, Heimburger O, Barany P, Stenvinkel P, Lindholm B.
    Perit Dial Int; 2016 Jun 14; 36(3):269-76. PubMed ID: 26493750
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Circulating levels of soluble receptor for advanced glycation end product are inversely associated with vascular calcification in patients on haemodialysis independent of S100A12 (EN-RAGE) levels.
    Kim HS, Chung W, Kim AJ, Ro H, Chang JH, Lee HH, Jung JY.
    Nephrology (Carlton); 2013 Dec 14; 18(12):777-82. PubMed ID: 24124651
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Effect of circulating soluble receptor for advanced glycation end products (sRAGE) and the proinflammatory RAGE ligand (EN-RAGE, S100A12) on mortality in hemodialysis patients.
    Nakashima A, Carrero JJ, Qureshi AR, Miyamoto T, Anderstam B, Bárány P, Heimbürger O, Stenvinkel P, Lindholm B.
    Clin J Am Soc Nephrol; 2010 Dec 14; 5(12):2213-9. PubMed ID: 20847094
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Modulation of soluble receptor for advanced glycation end products isoforms and advanced glycation end products in long-living individuals.
    Scavello F, Tedesco CC, Castiglione S, Maciag A, Sangalli E, Veglia F, Spinetti G, Puca AA, Raucci A.
    Biomark Med; 2021 Aug 14; 15(11):785-796. PubMed ID: 34236256
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Circulating soluble receptor for advanced glycation end products is inversely associated with glycemic control and S100A12 protein.
    Basta G, Sironi AM, Lazzerini G, Del Turco S, Buzzigoli E, Casolaro A, Natali A, Ferrannini E, Gastaldelli A.
    J Clin Endocrinol Metab; 2006 Nov 14; 91(11):4628-34. PubMed ID: 16926247
    [Abstract] [Full Text] [Related]

  • 16. Association Between Soluble Receptor for Advanced Glycation End Product and Endogenous Secretory Soluble Receptor for Advanced Glycation End Product Levels and Carotid Atherosclerosis in Diabetes: A Systematic Review and Meta-Analysis.
    Wang X, Wang Q, Wei D, Chang X.
    Can J Diabetes; 2021 Oct 14; 45(7):634-640. PubMed ID: 33773934
    [Abstract] [Full Text] [Related]

  • 17. Serum levels of soluble receptor for advanced glycation end products and of S100 proteins are associated with inflammatory, autoantibody, and classical risk markers of joint and vascular damage in rheumatoid arthritis.
    Chen YS, Yan W, Geczy CL, Brown MA, Thomas R.
    Arthritis Res Ther; 2009 Oct 14; 11(2):R39. PubMed ID: 19284577
    [Abstract] [Full Text] [Related]

  • 18. Receptor for advanced glycation end products polymorphisms in coronary artery ectasia.
    Aslan EI, Ozkara G, Kilicarslan O, Ser OS, Bostan C, Yildiz A, Diren Borekcioglu A, Ozturk O, Kucukhuseyin O, Yilmaz Aydogan H.
    Gene; 2024 Jul 20; 916():148450. PubMed ID: 38588932
    [Abstract] [Full Text] [Related]

  • 19. A drop in the circulating concentrations of soluble receptor for advanced glycation end products is associated with seroconversion to autoantibody positivity but not with subsequent progression to clinical disease in children en route to type 1 diabetes.
    Salonen KM, Ryhänen SJ, Forbes JM, Härkönen T, Ilonen J, Simell O, Veijola R, Groop PH, Knip M.
    Diabetes Metab Res Rev; 2017 May 20; 33(4):. PubMed ID: 27883367
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 32.